Sex Difference in Long-Term Survival After Coronary Artery Bypass Grafting Is Age-Dependent

Joost F Ter Woorst1, Jules R Olsthoorn1, Saskia Houterman2

  • 1Department of Cardiothoracic Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Insights

Women undergoing coronary artery bypass grafting (CABG) have higher early mortality. However, after propensity score matching, female sex is not an independent risk factor for long-term survival after CABG.

Area of Science:

  • Cardiovascular Surgery
  • Surgical Outcomes
  • Gender Disparities in Medicine

Background:

  • Coronary artery bypass grafting (CABG) is a common cardiac procedure.
  • Women undergoing CABG historically show higher postoperative morbidity and mortality rates compared to men.
  • Understanding gender-specific outcomes in CABG is crucial for optimizing patient care.

Purpose of the Study:

  • To compare the patient profile and long-term outcomes of men and women undergoing isolated CABG.
  • To investigate potential gender-based differences in survival after CABG.
  • To identify risk factors affecting long-term survival in female CABG patients.

Main Methods:

  • Retrospective analysis of patient records from a single center (Catharina Hospital, Eindhoven, The Netherlands).
  • Inclusion of 17,483 patients who underwent isolated CABG between January 1998 and December 2015.
  • Propensity score-matched analysis to control for baseline differences between male and female patients.

Main Results:

  • Women were older and had lower preoperative hemoglobin levels than men.
  • Significantly higher early (30-day) and one-year mortality rates were observed in women.
  • After propensity score matching, female sex was not an independent predictor of long-term survival, except in patients younger than 70 years.

Conclusions:

  • Female sex is not an independent risk factor for long-term survival after CABG when adjusted for other factors.
  • Poorer long-term survival in women post-CABG was primarily observed in the younger patient cohort (<70 years).
  • Further research may explore specific factors contributing to observed differences in younger female patients.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
43
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
350
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
218
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
86
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
22
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
22